Vitamin D status, liver enzymes, and incident liver disease and mortality: A general population study

Endocrine

Volumn 47, Issue 1, 2014, Pages 213-220

  Skaaby, Tea ^a   Husemoen, Lise Lotte Nystrup ^a   Borglykke, Anders ^a   Jørgensen, Torben ^a,b,c   Thuesen, Betina Heinsbæk ^a   Pisinger, Charlotta ^a   Schmidt, Lars Ebbe ^a   Linneberg, Allan ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Alanine transaminase (ALT); Aspartate transaminase (AST); Gamma glutamyl transferase (GGT); Liver disease; Liver enzymes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; VITAMIN D;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CAUSE OF DEATH; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE REGISTRY; EDUCATIONAL STATUS; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; SEASONAL VARIATION; SEX DIFFERENCE; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; ENZYMOLOGY; INCIDENCE; LIVER; LIVER DISEASES; LIVER FUNCTION TEST; MIDDLE AGED;

ADULT; AGED; DENMARK; FEMALE; HUMANS; INCIDENCE; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MORTALITY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84906936079     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0107-8     Document Type: Article

References (42)

1. M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357(3), 266-281 (2007)
2. T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, M. Fenger et al., Vitamin D status and cause-specific mortality: a general population study. PLoS ONE 7(12), e52423 (2012)
3. T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, M. Fenger et al., Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology 123(1), 62-70 (2012)
4. T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, M. Fenger et al., Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43(3), 618-625 (2013)
5. T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, K. Rasmussen et al., Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine 44 (2), 473-480 (2013)
6. T. Skaaby, L.L. Husemoen, T. Martinussen, J.P. Thyssen, M. Melgaard, B.H. Thuesen et al., Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS ONE 8(2), e57647 (2013)
7. L.L. Husemoen, T. Skaaby, B.H. Thuesen, T. Jorgensen, R.V. Fenger, A. Linneberg, Serum 25(OH)D and incident type 2 diabetes: a cohort study. Eur. J. Clin. Nutr. 66 (12), 1309-1314 (2012)
8. J. Arteh, S. Narra, S. Nair, Prevalence of vitamin D deficiency in chronic liver disease. Dig. Dis. Sci. 55(9), 2624-2628 (2010)
9. M. Malham, S.P. Jorgensen, P. Ott, J. Agnholt, H. Vilstrup, M. Borre et al., Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J. Gastroenterol. 17(7), 922-925 (2011)
10. A. Rode, S. Fourlanos, A. Nicoll, Oral vitamin D replacement is effective in chronic liver disease. Gastroenterol. Clin. Biol. 34(11), 618-620 (2010)
11. S. Zuniga, D. Firrincieli, C. Housset, N. Chignard, Vitamin D and the vitamin D receptor in liver pathophysiology. Clin. Res. Hepatol. Gastroenterol. 35 (4), 295-302 (2011)
12. H.M. Pappa, E. Bern, D. Kamin, R.J. Grand, Vitamin D status in gastrointestinal and liver disease. Curr. Opin. Gastroenterol. 24(2), 176-183 (2008)
13. C. Putz-Bankuti, S. Pilz, T. Stojakovic, H. Scharnagl, T.R. Pieber, M. Trauner et al., Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 32(5), 845-851 (2012)
14. A. Vogel, C.P. Strassburg, M.P. Manns, Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35(1), 126-131 (2002)
15. L. Fan, X. Tu, Y. Zhu, L. Zhou, T. Pfeiffer, R. Feltens et al., Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J. Gastroenterol. Hepatol. 20(2), 249-255 (2005)
16. J.J. Potter, X. Liu, A. Koteish, E. Mezey, 1,25-Dihydroxyvitamin D3 and its nuclear receptor repress human alpha(1) (I) collagen expression and type I collagen formation. Liver Int. 33(5), 677-686 (2013)
17. G.D. Carter, R. Carter, J. Jones, J. Berry, How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin. Chem. 50(11), 2195-2197 (2004)
18. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, J.H. Olsen, The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan. Med. Bull. 46(3), 263-268 (1999)
19. K. Juel, K. Helweg-Larsen, The Danish registers of causes of death. Dan. Med. Bull. 46(4), 354-357 (1999)
20. M. Osler, B.L. Heitmann, S. Hoidrup, L.M. Jorgensen, M. Schroll, Food intake patterns, self rated health and mortality in Danish men and women. A prospective observational study. J. Epidemiol. Commun. Health 55 (6), 399-403 (2001)
21. Liver disease in Europe. Lancet. 381(9866), 508 (2013)
22. M. Heron, Deaths: leading causes for 2004. Natl. Vital. Stat. Rep. 56(5), 1-95 (2007)
23. F.A. Rochling, Evaluation of abnormal liver tests. Clin. Cornerstone 3(6), 1-12 (2001)
24. C.E. Ruhl, J.E. Everhart, Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 136(2), 477-485 (2009)
25. L. Wang, J. Zhang, B. Wang, Y. Zhang, J. Hong, Y. Zhang, et al. New evidence for an association between liver enzymes and pancreatic islet b-cell dysfunction in young obese patients. Endocrine. (2013). doi:10.1007/s12020-013- 9937-7
26. Y.N. Flores, H.F. Yee Jr, M. Leng, J.J. Escarce, R. Bastani, J. Salmeron et al., Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am. J. Gastroenterol. 103(9), 2231-2238 (2008)
27. J. Arteh, S. Narra, S. Nair, Prevalence of vitamin D deficiency in chronic liver disease. Dig. Dis. Sci. 55(9), 2624-2628 (2010)
28. L. Fisher, A. Fisher, Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin. Gastroenterol. Hepatol. 5(4), 513-520 (2007)
29. R. Bouillon, G. Carmeliet, L. Verlinden, E.E. van, E.E. Verstuyf, H.F. Luderer et al., Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29(6), 726-776 (2008)
30. D.D. Bikle, Vitamin D insufficiency/deficiency in gastrointestinal disorders. J. Bone Miner. Res. 22(Suppl 2), V50-V54 (2007)
31. S. Petta, C. Camma, C. Scazzone, C. Tripodo, M.V. Di, A. Bono et al., Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 51 (4), 1158-1167 (2010)
32. E. Scorletti, P.C. Calder, C.D. Byrne, Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 40(3), 332-343 (2011)
33. Y. Colak, E. Senates, A. Yesil, Y. Yilmaz, O. Ozturk, L. Doganay et al., Assessment of endothelial function in patients with non-alcoholic fatty liver disease. Endocrine 43(1), 100-107 (2013)
34. G. Targher, L. Bertolini, L. Scala, M. Cigolini, L. Zenari, G. Falezza et al., Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 17(7), 517-524 (2007)
35. I. Barchetta, F. Angelico, B.M. Del, M.G. Baroni, P. Pozzilli, S. Morini et al., Strong association between non-alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 9, 85 (2011)
36. B. Thuesen, L. Husemoen, M. Fenger, J. Jakobsen, P. Schwarz, U. Toft et al., Determinants of vitamin D status in a general population of Danish adults. Bone 50(3), 605-610 (2012)
37. W.B. Grant, Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinology 3(3), 199-204 (2011)
38. W.B. Grant, Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinology 4(2), 198-202 (2012)
39. R. Jorde, M. Sneve, M. Hutchinson, N. Emaus, Y. Figenschau, G. Grimnes, Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am. J. Epidemiol. 171(8), 903-908 (2010)
40. K.E. Corey, H. Zheng, J. Mendez-Navarro, A. Delgado-Borrego, J.L. Dienstag, R.T. Chung, Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS ONE 7(2), e27144 (2012)
41. S.J. Weintraub, J.F. Fleckenstein, T.N. Marion, M.A. Madey, T.M. Mahmoudi, K.B. Schechtman, Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response. Am. J. Clin. Nutr. 96(5), 1025-1031 (2012)
42. D.L. White, S. Tavakoli-Tabasi, F. Kanwal, D.J. Ramsey, A. Hashmi, J. Kuzniarek et al., The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment. Pharmacol. Ther. 38(1), 28-37 (2013)